DK1124582T3 - Konserveringssystem til topisk indgivelige farmaceutiske præparater - Google Patents

Konserveringssystem til topisk indgivelige farmaceutiske præparater

Info

Publication number
DK1124582T3
DK1124582T3 DK99951565T DK99951565T DK1124582T3 DK 1124582 T3 DK1124582 T3 DK 1124582T3 DK 99951565 T DK99951565 T DK 99951565T DK 99951565 T DK99951565 T DK 99951565T DK 1124582 T3 DK1124582 T3 DK 1124582T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
preservation system
deliverable pharmaceutical
topically
topically deliverable
Prior art date
Application number
DK99951565T
Other languages
Danish (da)
English (en)
Inventor
Ernesto J Castillo
Wesley Wehsin Han
Steven Howard Gerson
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Application granted granted Critical
Publication of DK1124582T3 publication Critical patent/DK1124582T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
DK99951565T 1998-10-27 1999-09-21 Konserveringssystem til topisk indgivelige farmaceutiske præparater DK1124582T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10582098P 1998-10-27 1998-10-27

Publications (1)

Publication Number Publication Date
DK1124582T3 true DK1124582T3 (da) 2004-03-22

Family

ID=22307959

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99951565T DK1124582T3 (da) 1998-10-27 1999-09-21 Konserveringssystem til topisk indgivelige farmaceutiske præparater

Country Status (14)

Country Link
US (1) US6211238B1 (fr)
EP (1) EP1124582B1 (fr)
JP (1) JP2002528423A (fr)
AR (1) AR020964A1 (fr)
AT (1) ATE255909T1 (fr)
AU (1) AU758450B2 (fr)
BR (1) BR9914813A (fr)
CA (1) CA2340226A1 (fr)
DE (1) DE69913559T2 (fr)
DK (1) DK1124582T3 (fr)
ES (1) ES2209515T3 (fr)
PT (1) PT1124582E (fr)
TW (1) TW534816B (fr)
WO (1) WO2000024425A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444710B1 (en) 1998-10-27 2002-09-03 Alcon Manufacturing, Ltd. Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
US6146622A (en) * 1998-10-27 2000-11-14 Alcon Laboratories, Inc. Use of certain anionic amino acid based surfactants to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions
ES2171147B1 (es) * 2001-02-06 2003-12-16 Esteve Labor Dr Preparacion para usos veterinarios.
JP4424643B2 (ja) * 2002-02-13 2010-03-03 株式会社バイオバンク 抗真菌剤の製造方法
JP4725699B2 (ja) * 2002-04-08 2011-07-13 ライオン株式会社 眼科用組成物及び眼科用組成物配合用防腐剤
JP2010031052A (ja) * 2002-04-08 2010-02-12 Lion Corp 眼科用組成物、及び眼科製剤用防腐組成物
AU2003230890A1 (en) * 2002-04-11 2003-10-27 Dvm Pharmaceuticals, Inc. Antimicrobial wash and carrier solutions, and uses thereof
US20040101506A1 (en) * 2002-11-25 2004-05-27 Fust Charles A. Composition for the prevention and treatment of inflammation of the ear
US20060177430A1 (en) * 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
CN1753683B (zh) * 2002-12-20 2010-05-26 视可舒研究公司 预防和治疗不良眼部病症的眼用制剂
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US7214391B2 (en) * 2003-06-30 2007-05-08 Usana Health Sciences, Inc. Botanical extract compositions and process for preparing same
US20060019987A1 (en) * 2004-07-23 2006-01-26 Fust Charles A Methods and compositions for inhibiting, destroying, and/or inactivating viruses
US7678578B2 (en) * 2005-02-07 2010-03-16 Beckman Coulter, Inc. Cell permeabilization and stabilization reagent and method of use
EP1907006A2 (fr) * 2005-07-15 2008-04-09 Chakshu Research, Inc. Procede pour prevenir et traiter des complications ophtalmiques du diabete
WO2008024846A2 (fr) * 2006-08-25 2008-02-28 Allergan, Inc. Compositions de brimonidine et de timolol
SG186782A1 (en) * 2010-07-02 2013-02-28 Holden Brien Vision Inst Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
JP5870459B2 (ja) * 2010-08-27 2016-03-01 わかもと製薬株式会社 点眼用水性組成物
JP6315615B2 (ja) 2012-05-03 2018-04-25 ビュシャン，ラジブ 輸送エンハンサーとしてメチルスルホニルメタンを備えた金属モジュレーターを使用する、炎症疾患の処置及び口腔衛生の改善
WO2016205574A1 (fr) * 2015-06-18 2016-12-22 Common Pharma, Inc Formulations antimicrobiennes
WO2018111383A1 (fr) * 2016-12-16 2018-06-21 Vertellus Holdings Llc Formulations d'amine quaternaire et leurs utilisations
WO2018185788A1 (fr) * 2017-04-07 2018-10-11 Sun Pharma Advanced Research Company Limited Solution ophtalmique de bimatoprost
CN108066283B (zh) * 2017-12-28 2020-03-24 兆科（广州）眼科药物有限公司 一种盐酸左倍他洛尔滴眼液的制备方法
JP6653037B2 (ja) * 2018-03-30 2020-02-26 千寿製薬株式会社 水性液剤
WO2019189721A1 (fr) * 2018-03-30 2019-10-03 千寿製薬株式会社 Solution aqueuse

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275503A (en) 1964-08-26 1966-09-27 Patterson Co C Method for the protection of loci susceptible to the growth of undesired microorganisms
US4380637A (en) 1978-11-30 1983-04-19 Johnson & Johnson/Mona Industries, Inc. Imidazoline phosphobetaines
US4485029A (en) 1984-03-19 1984-11-27 Minnesota Mining And Manufacturing Company Disinfecting method and compositions
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
US4911920A (en) 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
GB2172298B (en) 1985-03-01 1988-11-23 Procter & Gamble Mild detergent mousse
CA1302280C (fr) 1986-04-21 1992-06-02 Jon Joseph Kabara Compositions et methodes pharmaceutiques antimicrobiennes topiques
US5000868A (en) 1987-04-03 1991-03-19 Wittpenn Jr John R Surfactant compositions
US5093126A (en) 1987-09-26 1992-03-03 Alcon Laboratories, Inc. Glaucoma formulations comprising an anionic, polysulfonic acid polymer having mucomimetic properties and a polystyrene sulfonic polymer
AU666957B2 (en) 1992-08-28 1996-02-29 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
US5520920A (en) 1992-08-28 1996-05-28 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
US5504113A (en) 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
US5536305A (en) 1994-06-08 1996-07-16 Yu; Bing Low leaching compositions for wood
PL181005B1 (pl) 1994-06-20 2001-05-31 Unilever Nv Mikrobójcza kompozycja czyszcząca
AU3070395A (en) 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US5494937A (en) 1994-07-22 1996-02-27 Alcon Laboratories, Inc. Saline solution for treating contact lenses
US5641480A (en) 1994-12-08 1997-06-24 Lever Brothers Company, Division Of Conopco, Inc. Hair care compositions comprising heteroatom containing alkyl aldonamide compounds
EP0877600B1 (fr) * 1996-08-09 2003-10-22 Alcon Manufacturing Ltd. Systemes conservateurs pour compositions pharmaceutiques contenant des cyclodextrines
GB9717952D0 (en) * 1997-08-22 1997-10-29 Procter & Gamble Cleansing compositions

Also Published As

Publication number Publication date
WO2000024425A1 (fr) 2000-05-04
CA2340226A1 (fr) 2000-05-04
EP1124582B1 (fr) 2003-12-10
BR9914813A (pt) 2001-07-03
ES2209515T3 (es) 2004-06-16
AR020964A1 (es) 2002-06-05
EP1124582A1 (fr) 2001-08-22
DE69913559T2 (de) 2004-11-11
AU6398299A (en) 2000-05-15
TW534816B (en) 2003-06-01
ATE255909T1 (de) 2003-12-15
JP2002528423A (ja) 2002-09-03
US6211238B1 (en) 2001-04-03
AU758450B2 (en) 2003-03-20
DE69913559D1 (de) 2004-01-22
PT1124582E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
DK1124582T3 (da) Konserveringssystem til topisk indgivelige farmaceutiske præparater
NO974618D0 (no) Farmasöytiske preparater for intranasal administrasjon
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
EE200200038A (et) Konservitud farmatseutilised preparaadid
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
NO20004391D0 (no) Duftforsterkende preparater for kosmetikkprodukter
NO986023D0 (no) Vannbaserte farmas÷ytiske preparater
DK1073417T3 (da) Farmaceutisk aerosolformulering
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
DE69711045T2 (de) Vitamin c abgabesystem
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20030139D0 (no) Farmasöytiske preparater inneholdende DDS forbindelser
ATE266383T1 (de) Dermatologische zubereitungen
DE50006410D1 (de) Verpackungssystem für kosmetische formulierungen
DK1056343T3 (da) Vandholdige parasiticidpræparater til dermal påföring
PT813876E (pt) Preparacoes contendo ciclosporina para capsulas moles
NO983464D0 (no) Buffersystemer for stabilisering av farmas°ytiske preparater
NO990956L (no) Klorfluorkarbonfrie mometasonfuroataerosolpreparater
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
ID16781A (id) Formulasi-formulasi farmasi
DE69926012D1 (de) Arzneizubereitungen
NO983540L (no) Farmas°ytiske preparater inneholdende cilansetron som er stabilisert mot racemisering
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
DK48993D0 (da) Forstoevningsapparat til vandbaaret lungemedicin